Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1978 1
1994 1
1995 1
1998 1
1999 3
2000 2
2002 5
2003 2
2004 3
2005 7
2006 6
2007 5
2008 6
2009 9
2010 3
2011 1
2012 7
2013 8
2014 5
2015 3
2016 6
2017 4
2018 7
2019 6
2020 4
2021 1
2022 8
2023 6
2024 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Reply.
Mammo Z, Guo M, Maberley D, Matsubara J, Etminan M. Mammo Z, et al. Among authors: maberley d. Am J Ophthalmol. 2017 Apr;176:255-256. doi: 10.1016/j.ajo.2017.01.009. Epub 2017 Feb 9. Am J Ophthalmol. 2017. PMID: 28190509 No abstract available.
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group. Haller JA, et al. Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24. Ophthalmology. 2010. PMID: 20417567 Clinical Trial.
Risk of ocular adverse events with aromatase inhibitors.
Feng ZX, Sriranganathan A, Lo C, Liu V, Maberley D, Etminan M. Feng ZX, et al. Among authors: maberley d. Can J Ophthalmol. 2024 Oct;59(5):e431-e434. doi: 10.1016/j.jcjo.2023.10.013. Epub 2023 Nov 3. Can J Ophthalmol. 2024. PMID: 37931898
Systematic review of Purtscher's and Purtscher-like retinopathies.
Miguel AI, Henriques F, Azevedo LF, Loureiro AJ, Maberley DA. Miguel AI, et al. Among authors: maberley da. Eye (Lond). 2013 Jan;27(1):1-13. doi: 10.1038/eye.2012.222. Epub 2012 Nov 23. Eye (Lond). 2013. PMID: 23174749 Free PMC article. Review.
PDGF receptors are activated in human epiretinal membranes.
Cui J, Lei H, Samad A, Basavanthappa S, Maberley D, Matsubara J, Kazlauskas A. Cui J, et al. Among authors: maberley d. Exp Eye Res. 2009 Mar;88(3):438-44. doi: 10.1016/j.exer.2008.10.020. Epub 2008 Nov 8. Exp Eye Res. 2009. PMID: 19032953 Free PMC article.
Diabetic retinopathy screening.
Boucher MC, Desroches G, Garcia-Salinas R, Kherani A, Maberley D, Olivier S, Oh M, Stockl F. Boucher MC, et al. Among authors: maberley d. Can J Ophthalmol. 2009 Feb;44(1):100-1. doi: 10.3129/i08-192. Can J Ophthalmol. 2009. PMID: 19169324 No abstract available.
115 results